190 related articles for article (PubMed ID: 20583556)
1. [Efficacy of cytoflavin in therapy of encephalophathy in patients with neuroinfection].
Isakov VA; Kovalenko AL; Turkin VV; Makarov VI
Antibiot Khimioter; 2010; 55(1-2):36-41. PubMed ID: 20583556
[TBL] [Abstract][Full Text] [Related]
2. [Use of cytoflavin into the complex intensive therapy of acute cerebral insufficiency caused by poisoning].
Vasilyev S; Shilov V; Aleksandrov M; Batotsyrenov B; Loladze A
Georgian Med News; 2012 Feb; (203):22-9. PubMed ID: 22466536
[TBL] [Abstract][Full Text] [Related]
3. [Pharmacotherapy of basic clinical presentations of chronic brain ischemia].
Madzhidova EN; Usmanova DD; Baĭtursunova ZhM
Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(8 Pt 1):60-2. PubMed ID: 21946144
[No Abstract] [Full Text] [Related]
4. [Rationale of application of the drug Cytoflavin in complex treatment of patients with diabetic foot syndrome with mediacalcification arteries].
Mikhaloĭko IIa; Sabadosh RV; Kovalenko AL; Skripko VD
Khirurgiia (Mosk); 2014; (12):36-40. PubMed ID: 25589316
[TBL] [Abstract][Full Text] [Related]
5. [Methods for the prevention and treatment of toxico-hypoxic encephalopathy in patients with acute severe poisoning].
Klin Med (Mosk); 2011; 89(6):56-9. PubMed ID: 22420197
[TBL] [Abstract][Full Text] [Related]
6. [THE PHARMACOTHERAPEUTIC EFFICIENCY OF CYTOFLAVIN IN PATIENTS WITH DIABETIC FOOT SYNDROME: IMMEDIATE AND LONG-TERM RESULTS].
Markevich PS; Markevich LB; Plekhanov AN; Kovalenko AL
Klin Med (Mosk); 2015; 93(6):67-72. PubMed ID: 26495531
[TBL] [Abstract][Full Text] [Related]
7. [Efficacy of cytoflavin in the treatment of vertebrobasilar insufficiency].
Beĭn BN; Dravert NE
Eksp Klin Farmakol; 2010 Apr; 73(4):8-10. PubMed ID: 20486551
[TBL] [Abstract][Full Text] [Related]
8. [Effect of cytoflavin on some physiological values in patients with toxicohypoxic encephalopathy].
Livanov GA; Lodiagin AN; Andrianov AIu; Batotsyrenov BV; Nikolaeva IP
Eksp Klin Farmakol; 2013; 76(11):40-3. PubMed ID: 24555233
[TBL] [Abstract][Full Text] [Related]
9. [Therapeutic efficiency of cytoflavine solution for infusion in emergency conditions].
Suslina ZA; Romantsov MG; Kovalenko AL; Klocheva EG; Rumintseva SA; Bagnenko SF; Piradov MA; Semke VIa; Sukhanov DS
Klin Med (Mosk); 2010; 88(4):61-7. PubMed ID: 20919573
[TBL] [Abstract][Full Text] [Related]
10. [Using cytoflavin for prophylaxis and treatment of cognitive amnestic disorders in patients with heavy toxicohypoxic damage of brain].
Batotsyrenova KhV; Livanov GA; Shestova GV; Sizova KV; Velikova VD
Eksp Klin Farmakol; 2012; 75(9):28-31. PubMed ID: 23156085
[TBL] [Abstract][Full Text] [Related]
11. [Clinical effectiveness of cytoflavin inclusion in intensive care of patients with combined traumatic brain injury].
Lebedeva EA; Kurtasov AA; Belousova ME; Nemkova ZA; Kaminskiĭ MIu; Popov RV; Trofimovich SL
Eksp Klin Farmakol; 2014; 77(4):42-4. PubMed ID: 25076759
[TBL] [Abstract][Full Text] [Related]
12. [Efficiency of intensive care with cytoflavin in patients of advanced age in combined traumatic brain injury].
Lebedeva EA; Belousova ME; Kurtasov AA; Nemkova ZA; Kaminskiĭ MIu; Popov RV; Trofimovich SL
Adv Gerontol; 2014; 27(3):578-83. PubMed ID: 25827011
[TBL] [Abstract][Full Text] [Related]
13. [Prevention of cognitive dysfunction in patients operated on thyroid gland].
Golub IE; Pinskiĭ SB; Sorokina LV; Ivankova EN; Kovalenko AL
Khirurgiia (Mosk); 2011; (10):74-7. PubMed ID: 22334909
[TBL] [Abstract][Full Text] [Related]
14. [Positive effect of cytoflavin on metabolic status changes in patients with burn disorder].
Polutova NV; Ostrovskiĭ NV; Romantsov MG; Chesnokova NP
Eksp Klin Farmakol; 2011; 74(7):33-7. PubMed ID: 21894767
[TBL] [Abstract][Full Text] [Related]
15. [Assessment of multimodal effect of cytoflavin in the acute brain stroke in patients with metabolic syndrome].
Asadullaev MM; Saidvaliev FS; Shermukhamedova FK; Rizvonov ZhK; Vakhabova NM
Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(10):24-7. PubMed ID: 23250593
[TBL] [Abstract][Full Text] [Related]
16. [The assessment of the effects of cytoflavin and cardioxipin on the emotional status of rats with dyslipidemia].
Vodop'ianova OA; Moiseeva IIa; Rodina OP; Kustikova IN; Antropova NV
Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(7):53-5. PubMed ID: 25176268
[TBL] [Abstract][Full Text] [Related]
17. [Features of psychopharmacotherapeutic correction of alcohol dependence in the elderly].
Belov VG; Parfenov IuA; Zaplutanov VA
Adv Gerontol; 2013; 26(4):702-6. PubMed ID: 24738263
[TBL] [Abstract][Full Text] [Related]
18. [The use of cytoflavin in sports nutrition].
Kosinets VA; Stolbitskiĭ VV; Shturich IP
Klin Med (Mosk); 2012; 90(7):56-8. PubMed ID: 23019978
[TBL] [Abstract][Full Text] [Related]
19. [Cytoflavin rationale for the use in treatment of patients with postsurgical hypothyroidism].
Skripkо VD; Pasko AJ; Kovalenko AL; Zaplutanov VA
Khirurgiia (Mosk); 2016; (7):53-57. PubMed ID: 27459489
[TBL] [Abstract][Full Text] [Related]
20. [Clinical and morphologic efficacy of a complex antioxidant and energy correction therapy of different duration in brain infarction: results of a multicenter randomized trial].
Rumyantsevа SA; Kovalenko AL; Silinа EV; Stupin VA; Kabaeva EN; Chichanovskaya LV; Nazarov MV; Tsukurova LA; Burenichev DV; Golikov KV; Salnikov MV; Belova LA; Mashin VV; Mazina NK; Zhilina EA; Kolotik-Kameneva OY; Sherman MA
Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(8):45-52. PubMed ID: 26356615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]